Status:
COMPLETED
Iron Status and Myelination in Premature Infants
Lead Sponsor:
University of Rochester
Conditions:
Neurodevelopmental Outcome
Eligibility:
All Genders
Up to 32 years
Phase:
NA
Brief Summary
Premature infants with iron deficiency if supplemented with more elemental iron than the routine 2mg/kg/day will have improved brain development.
Eligibility Criteria
Inclusion
- Babies less than or equal to 33 weeks gestational age
Exclusion
- Infants with cranio-facial malformations
- Torch infections
- Infants with hearing disorders
- Infants receiving erythropoietin
- Infants with subnormal vitamin E levels
- Infants with severe anemia
- Infants who are not on full feeds
- Infant with in-utero exposure to cocaine
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00684697
Start Date
May 1 2009
End Date
December 31 2020
Last Update
March 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642